X chromosome and ovarian failure

Seminars in Reproductive Medicine

Volumn 25, Issue 4, 2007, Pages 264-271

  Toniolo, Daniela ^a   Rizzolio, Flavio ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Infertility; Premature ovarian failure; X chromosome monosomy

Indexed keywords

BONE MORPHOGENETIC PROTEIN 15; FRAGILE X MENTAL RETARDATION PROTEIN;

DNA SEQUENCE; FEMALE INFERTILITY; GENE REARRANGEMENT; GENETIC DISORDER; HUMAN; OVARY INSUFFICIENCY; PREMATURE OVARIAN FAILURE; REVIEW; RISK FACTOR; SEX CHROMOSOME; TURNER SYNDROME; X CHROMOSOME;

CHROMOSOME DELETION; CHROMOSOMES, HUMAN, X; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; GENE REARRANGEMENT; GENES, X-LINKED; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFERTILITY, FEMALE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MUTATION; OVARIAN FAILURE, PREMATURE; OVULATION; RISK FACTORS; SEX CHROMOSOME DISORDERS; TURNER SYNDROME;

EID: 34447293282     PISSN: 15268004     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-980220     Document Type: Review

References (96)

1. Charlesworth D, Charlesworth B, Marais G. Steps in the evolution of heteromorphic sex chromosomes. Heredity 2005;95:118-128
2. Lahn BT, Pearson NM, Jegalian K. The human Y chromosome, in the light of evolution. Nat Rev Genet 2001;2:207-216
3. Bachtrog D. A dynamic view of sex chromosome evolution. Curr Opin Genet Dev 2006;16:578-585
4. Lahn BT, Page DC. Four evolutionary strata on the human X chromosome. Science 1999;286:964-967
5. Vallender EJ, Lahn BT. How mammalian sex chromosomes acquired their peculiar gene content. Bioessays 2004;26:159-169
6. Vicoso B, Charlesworth B. Evolution on the X chromosome: unusual patterns and processes. Nat Rev Genet 2006;7:645-653
7. Graves JA. Sex chromosome specialization and degeneration in mammals. Cell 2006;124:901-914
8. Clerc P, Avner P. Random X-chromosome inactivation: skewing lessons for mice and men. Curr Opin Genet Dev 2006;16:246-253
9. Carrel L, Willard HF. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 2005;434:400-404
10. Khil PP, Smirnova NA, Romanienko PJ, Camerini-Otero RD. The mouse X chromosome is enriched for sex-biased genes not subject to selection by meiotic sex chromosome inactivation. Nat Genet 2004;36:642-646
11. Zinn AR, Ross JL. Turner syndrome and haploinsufficiency. Curr Opin Genet Dev 1998;8:322-327
12. Rao E, Weiss B, Fukami M, et al. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet 1997;16:54-63
13. Belin V, Cusin V, Viot G, et al. SHOX mutations in dyschondrosteosis (Leri-Weill syndrome). Nat Genet 1998;19:67-69
14. Shears DJ, Vassal HJ, Goodman FR, et al. Mutation and deletion of the pseudoautosomal gene SHOX cause Leri-Weill dyschondrosteosis. Nat Genet 1998;19:70-73
15. Clement-Jones M, Schiller S, Rao E, et al. The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. Hum Mol Genet 2000;9:695-702
16. Gartler SM, Andina R, Gant N. Ontogeny of X-chromosome inactivation in the female germ line. Exp Cell Res 1975;91:454-457
17. Speed RM. The possible role of meiotic pairing anomalies in the atresia of human fetal oocytes. Hum Genet 1988;78:260-266
18. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986;67:604-606
19. Goswami D, Conway G. Premature ovarian failure. Hum Reprod Update 2005;11:391-410
20. Zinn AR, Tonk VS, Chen Z, et al. Evidence for a Turner syndrome locus or loci at Xp11.2-p22.1. Am J Hum Genet 1998;63:1757-1766
21. Ogata T, Muroya K, Matsuo N, et al. Turner syndrome and Xp deletions: clinical and molecular studies in 47 patients. J Clin Endocrinol Metab 2001;86:5498-5508
22. Lachlan KL, Youings S, Costa T, Jacobs PA, Thomas NS. A clinical and molecular study of 26 females with Xp deletions with special emphasis on inherited deletions. Hum Genet 2006;118:640-651
23. Simpson JL, Rajkovic A. Ovarian differentiation and gonadal failure. Am J Med Genet 1999;89:186-200
24. Ogata T, Matsuo N. Turner syndrome and female sex chromosome aberrations: deduction of the principal factors involved in the development of clinical features. Hum Genet 1995;95:607-629
25. Maraschio P, Tupler R, Barbierato L, et al. An analysis of Xq deletions. Hum Genet 1996;97:375-381
26. Marozzi A, Manfredini E, Tibiletti MG, et al. Molecular definition of Xq common-deleted region in patients affected by premature ovarian failure. Hum Genet 2000;107:304-311
27. Cremers FP, van de Pol DJ, Diergaarde PJ, et al. Physical fine mapping of the choroideremia locus using Xq21 deletions associated with complex syndromes. Genomics 1989;4:41-46
28. Krauss CM, Turksoy RN, Atkins L, et al. Familial premature ovarian failure due to an interstitial deletion of the long arm of the X chromosome. N Engl J Med 1987;317:125-131
29. Rizzolio F, Bione S, Sala C, et al. Chromosomal rearrangements in Xq and premature ovarian failure: mapping of 25 new cases and review of the literature. Hum Reprod 2006;21:1477-1483
30. Schwartz C, Fitch N, Phelan MC, Richer CL, Stevenson R. Two sisters with a distal deletion at the Xq26/Xq27 interface: DNA studies indicate that the gene locus for factor IX is present. Hum Genet 1987;76:54-57
31. Trunca C, Therman E, Rosenwaks Z. The phenotypic effects of small, distal Xq deletions. Hum Genet 1984;68:87-89
32. Rossetti F, Rizzolio F, Pramparo T, et al. A susceptibility gene for premature ovarian failure (POF) maps to proximal Xq28. Eur J Hum Genet 2004;12:829-834
33. Eggermann T, Meschede D, Schuler H, et al. Premature ovarian failure associated with a small terminal Xq deletion: narrowing the POF1 region down to Xq27.2/Xq27.3-qter. Clin Genet 2005;67:434-437
34. Fimiani G, Laperuta C, Falco G, et al. Heterozygosity mapping by quantitative fluorescent PCR reveals an interstitial deletion in Xq26.2-q28 associated with ovarian dysfunction. Hum Reprod 2006;21:529-535
35. Portnoi MF, Aboura A, Tachdjian G, et al. Molecular cytogenetic studies of Xq critical regions in premature ovarian failure patients. Hum Reprod 2006;21:2329-2334
36. Luborsky JL, Meyer P, Sowers MF, Gold EB, Santoro N. Premature menopause in a multi-ethnic population study of the menopause transition. Hum Reprod 2003;18:199-206
37. Moncayo R, Moncayo HE. Autoimmunity and the ovary. Immunol Today 1992;13:255-258
38. Luborsky J. Ovarian autoimmune disease and ovarian autoantibodies. J Womens Health Gend Based Med 2002;11:585-599
39. Aittomaki K, Lucena JL, Pakarinen P, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995;82:959-968
40. Di Pasquale E, Beck-Peccoz P, Persani L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet 2004;75:106-111
41. Crisponi L, Deiana M, Loi A, et al. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet 2001;27:159-166
42. Fogli A, Rodriguez D, Eymard-Pierre E, et al. Ovarian failure related to eukaryotic initiation factor 2B mutations. Am J Hum Genet 2003;72:1544-1550
43. Laml T, Preyer O, Umek W, Hengstschlager M, Hanzal H. Genetic disorders in premature ovarian failure. Hum Reprod Update 2002;8:483-491
44. Therman E, Susman B. The similarity of phenotypic effects caused by Xp and Xq deletions in the human female: a hypothesis. Hum Genet 1990;85:175-183
45. Therman E, Laxova R, Susman B. The critical region on the human Xq. Hum Genet 1990;85:455-461
46. Schlessinger D, Herrera L, Crisponi L, et al. Genes and translocations involved in POF. Am J Med Genet 2002;111:328-333
47. Turner JM, Mahadevaiah SK, Fernandez-Capetillo O, et al. Silencing of unsynapsed meiotic chromosomes in the mouse. Nat Genet 2005;37:41-47
48. Sala C, Arrigo G, Torri G, et al. Eleven X chromosome breakpoints associated with premature ovarian failure (POF) map to a 15-Mb YAC contig spanning Xq21. Genomics 1997;40:123-131
49. Mumm S, Herrera L, Waeltz PW, et al. X/autosomal translocations in the Xq critical region associated with premature ovarian failure fall within and outside genes. Genomics 2001;76:30-36
50. Prueitt RL, Chen H, Barnes RI, Zinn AR. Most Xjautosome translocations associated with premature ovarian failure do not interrupt X-linked genes. Cytogenet Genome Res 2002;97:32-38
51. Bione S, Sala C, Manzini C, et al. A human homologue of the Drosophila melanogaster diaphanous gene is disrupted in a patient with premature ovarian failure: evidence for conserved function in oogenesis and implications for human sterility. Am J Hum Genet 1998;62:533-541
52. Prueitt RL, Ross JL, Zinn AR. Physical mapping of nine Xq translocation breakpoints and identification of XPNPEP2 as a premature ovarian failure candidate gene. Cytogenet Cell Genet 2000;89:44-50
53. Duan QL, Nikpoor B, Dube MP, et al. A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors. Am J Hum Genet 2005;77:617-626
54. Rizzolio F, Bione S, Villa A, et al. Spatial and temporal expression of POF1B, a gene expressed in epithelia. Gene Expr Patterns 2007;7:529-534
55. Lacombe A, Lee H, Zahed L, et al. Disruption of POF1B binding to nonmuscle actin filaments is associated with premature ovarian failure. Am J Hum Genet 2006;79:113-119
56. Bione S, Rizzolio F, Sala C, et al. Mutation analysis of two candidate genes for premature ovarian failure, DACH2 and POF1B. Hum Reprod 2004;19:2759-2766
57. van Bokhoven H, Schwartz M, Andreasson S, et al. Mutation spectrum in the CHM gene of Danish and Swedish choroideremia patients. Hum Mol Genet 1994;3:1047-1051
58. Kleinjan DA, van Heyningen V. Long-range control of gene expression: emerging mechanisms and disruption in disease. Am J Hum Genet 2005;76:8-32
59. Rizzolio F, Sala C, Alboresi S, et al. Epigenetic control of the critical region for premature ovarian failure on autosomal genes translocated to the X chromosome: a hypothesis. Hum Genet 2007;121:441-450
60. Fassnacht W, Mempel A, Strowitzki T, Vogt PH. Premature ovarian failure (POF) syndrome: towards the molecular clinical analysis of its genetic complexity. Curr Med Chem 2006;13:1397-1410
61. Kingsley DM. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 1994;8:133-146
62. Hogan BL. Bmps: multifunctional regulators of mammalian embryonic development. Harvey Lect 1996;92:83-98
63. Drummond AE. TGFbeta signalling in the development of ovarian function. Cell Tissue Res 2005;322:107-115
64. Su YQ, Wu X, O'Brien MJ, et al. Synergistic roles of BMP15 and GDF9 in the development and function of the oocyte-cumulus cell complex in mice: genetic evidence for an oocyte-granulosa cell regulatory loop. Dev Biol 2004;276:64-73
65. McNatty KP, Juengel JL, Reader KL, et al. Bone morphogenetic protein 15 and growth differentiation factor 9 co-operate to regulate granulosa cell function in ruminants. Reproduction 2005;129:481-487
66. Galloway SM, McNatty KP, Cambridge LM, et al. Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet 2000;25:279-283
67. McNatty KP, Smith P, Moore LG, et al. Oocyte-expressed genes affecting ovulation rate. Mol Cell Endocrinol 2005;234:57-66
68. Layman LC. Editorial: BMP15 - the first true ovarian determinant gene on the X-chromosome? J Clin Endocrinol Metab 2006;91:1673-1676
69. Layman LC. Mutations in the follicle-stimulating hormone-beta (FSH beta) and FSH receptor genes in mice and humans. Semin Reprod Med 2000;18:5-10
70. Verkerk AJ, Pieretti M, Sutcliffe JS, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991;65:905-914
71. Oberle I, Rousseau F, Heitz D, et al. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 1991;252:1097-1102
72. Fu YH, Kuhl DP, Pizzuti A, et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 1991;67:1047-1058
73. Nolin SL, Brown WT, Glicksman A, et al. Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. Am J Hum Genet 2003;72:454-464
74. Tassone F, Hagerman RJ, Taylor AK, et al. Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet 2000;66:6-15
75. Kenneson A, Zhang F, Hagedorn CH, Warren ST. Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum Mol Genet 2001;10:1449-1454
76. Tassone F, Hagerman PJ. Expression of the FMR1 gene. Cytogenet Genome Res 2003;100:124-128
77. Feng Y, Zhang F, Lokey LK, et al. Translational suppression by trinucleotide repeat expansion at FMR1. Science 1995;268:731-734
78. Primerano B, Tassone F, Hagerman RJ, et al. Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations. RNA 2002;8:1482-1488
79. Beilina A, Tassone F, Schwartz PH, Sahota P, Hagerman PJ. Redistribution of transcription start sites within the FMR1 promoter region with expansion of the downstream CGG-repeat element. Hum Mol Genet 2004;13:543-549
80. Hagerman PJ, Hagerman RJ. The fragile-X premutation: a maturing perspective. Am J Hum Genet 2004;74:805-816
81. Schwartz CE, Dean J, Howard-Peebles PN, et al. Obstetrical and gynecological complications in fragile X carriers: a multicenter study. Am J Med Genet 1994;51:400-402
82. Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D, et al. Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study - preliminary data. Am J Med Genet 1999;83:322-325
83. Conway GS, Payne NN, Webb J, Murray A, Jacobs PA. Fragile X premutation screening in women with premature ovarian failure. Hum Reprod 1998;13:1184-1187
84. Bretherick KL, Fluker MR, Robinson WP. FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum Genet 2005;117:376-382
85. Bodega B, Bione S, Dalpra L, et al. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Hum Reprod 2005; In press
86. Uzielli ML, Guarducci S, Lapi E, et al. Premature ovarian failure (POF) and fragile X premutation females: from POF to fragile X carrier identification, from fragile X carrier diagnosis to POF association data. Am J Med Genet 1999;84:300-303
87. Murray A, Ennis S, MacSwiney F, Webb J, Morton NE. Reproductive and menstrual history of females with fragile X expansions. Eur J Hum Genet 2000;8:247-252
88. Murray A. Premature ovarian failure and the FMR1 gene. Semin Reprod Med 2000;18:59-66
89. Murray A, Webb J, MacSwiney F, et al. Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women. Hum Reprod 1999;14:1217-1218
90. Hundscheid RD, Braat DD, Kiemeney LA, Smits AP, Thomas CM. Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives. Hum Reprod 2001;16:457-462
91. Hundscheid RD, Sistermans EA, Thomas CM, et al. Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutations. Am J Hum Genet 2000;66:413-418
92. Sullivan AK, Marcus M, Epstein MP, et al. Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod 2005;20:402-412
93. Ennis S, Ward D, Murray A. Nonlinear association between CGG repeat number and age of menopause in FMR1 premutation carriers. Eur J Hum Genet 2006;14:253-255
94. Ebralidze A, Wang Y, Petkova V, Ebralidse K, Junghans RP. RNA leaching of transcription factors disrupts transcription in myotonic dystrophy. Science 2004;303:383-387
95. Vegetti W, Grazia Tibiletti M, Testa G, et al. Inheritance in idiopathic premature ovarian failure: analysis of 71 cases. Hum Reprod 1998;13:1796-1800
96. Matzuk MM, Lamb DJ. Genetic dissection of mammalian fertility pathways. Nat Cell Biol 2002;4(suppl):s41-s49